India vs Philippines: Average cost of tuberculosis treatment multi drug resistant
India
400
in 2024
Philippines
310
in 2024
India rank
87th
Philippines rank
89th
Average cost of tuberculosis treatment multi drug resistant over time
- India
- Philippines
How they compare
India currently reports 400 against 310 in Philippines, a difference of 90.
That makes India's figure about 1.3 times Philippines's.
The two have swapped places 3 times across 8 shared years of data; in 2017 it was Philippines ahead.
India ranks 87th and Philippines ranks 89th of 92 countries.
Philippines has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | India | Philippines | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1,700 | 4,921 | 3,221 | Philippines |
| 2020s | 444.2 | 1.36 million | 1.35 million | Philippines |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher average cost of tuberculosis treatment multi drug resistant, India or Philippines?
- India, at 400 against 310 in Philippines as of 2024.
- What is the difference in average cost of tuberculosis treatment multi drug resistant between India and Philippines?
- 90, with India ahead.
- How many years of comparable data are there for India and Philippines?
- 8 years are reported by both, from 2017 to 2024.
- How do India and Philippines rank globally for average cost of tuberculosis treatment multi drug resistant?
- India ranks 87th and Philippines ranks 89th of 92 countries.
- Where does this data come from?
- Our World in Data, published as Average cost of tuberculosis treatment multi drug resistant. Statizoid refreshes it automatically from the source and publishes the full history for both places.